Sagimet Biosciences Secures FDA Clearance for Acne Phase 3 Trial
FOSTER CITY, Calif., August 13, 2026 Sagimet Biosciences Inc. announced that the U.S. Food and Drug Administration (FDA) has...
IND clearance
Advertisement
Prime Medicine Achieves FDA Milestone for PM577a
CAMBRIDGE, Mass., July 23, 2026 Prime Medicine (Nasdaq: PRME) announced that the U.S. Food and Drug Administration (FDA) has...
UroGen Announces FDA Clearance of IND for UGN-501 in Bladder Cancer
PRINCETON, N.J., July 8, 2026 UroGen Pharma Ltd. announced that the U.S. Food and Drug Administration (FDA) has cleared...
LTZ Therapeutics Receives FDA IND Clearance for LTZ-232
REDWOOD CITY, Calif., July 7, 2026 LTZ Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared...
Palisade Bio Receives FDA IND Clearance for PALI-2108
DENVER, Colo., June 29, 2026 Palisade Bio, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared...
Advertisements
Gain Therapeutics Wins FDA IND Clearance for GT-02287
BETHESDA, Md., June 29, 2026 Gain Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared the...
Mabwell Receives China IND Clearance for 6MW5311 Cancer Therapy
SHANGHAI, June 23, 2026 Mabwell announced that China’s National Medical Products Administration (NMPA) has granted Investigational New Drug (IND)...
Amphista Therapeutics Receives FDA Clearance for AMX-883 AML Trial
CAMBRIDGE, UK, June 8, 2026 Amphista Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared the...
Mabwell Receives NMPA Clearance for 9MW5211 in Inflammatory Bowel Disease
SHANGHAI, China, June 5, 2026 Mabwell announced that China’s National Medical Products Administration (NMPA) has granted Investigational New Drug...
Cellenkos Secures FDA IND Clearance for CK0802 in GVHD Trial
HOUSTON, TEXAS, May 04, 2026 Cellenkos has announced that the U.S. Food and Drug Administration (FDA) has granted Investigational...
Advertisement
